Adjuvant Activity of Synthetic Lipid A of Alcaligenes , a Gut-Associated Lymphoid Tissue-Resident Commensal Bacterium, to Augment Antigen-Specific IgG and Th17 Responses in Systemic Vaccine

Vaccines
Yunru WangJun Kunisawa

Abstract

Alcaligenes spp. are identified as commensal bacteria and have been found to inhabit Peyer's patches in the gut. We previously reported that Alcaligenes-derived lipopolysaccharides (LPS) exerted adjuvant activity in systemic vaccination, without excessive inflammation. Lipid A is one of the components responsible for the biological effect of LPS and has previously been applied as an adjuvant. Here, we examined the adjuvant activity and safety of chemically synthesized Alcaligenes lipid A. We found that levels of OVA-specific serum IgG antibodies increased in mice that were subcutaneously immunized with ovalbumin (OVA) plus Alcaligenes lipid A relative to those that were immunized with OVA alone. In addition, Alcaligenes lipid A promoted antigen-specific T helper 17 (Th17) responses in the spleen; upregulated the expression of MHC class II, CD40, CD80, and CD86 on bone marrow-derived dendritic cells (BMDCs); enhanced the production of Th17-inducing cytokines IL-6 and IL-23 from BMDCs. Stimulation with Alcaligenes lipid A also induced the production of IL-6 and IL-1β in human peripheral blood mononuclear cells. Moreover, Alcaligenes lipid A caused minor side effects, such as lymphopenia and thrombocytopenia. These findings sugges...Continue Reading

References

Jun 1, 1996·European Journal of Immunology·J A Gracie, J A Bradley
Jul 1, 1970·Infection and Immunity·M Pollard, N Sharon
Jun 16, 2007·Science·Verónica Mata-HaroThomas C Mitchell
Jan 10, 2009·Annual Review of Immunology·Thomas KornVijay K Kuchroo
Jun 16, 2009·Seminars in Immunology·Daphne Y Ma, Edward A Clark
Oct 20, 2009·Cell·Ivaylo I IvanovDan R Littman
Apr 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Takashi ObataHiroshi Kiyono
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Meike MitsdoerfferVijay K Kuchroo
Dec 20, 2015·Immunity·Dhavalkumar D Patel, Vijay K Kuchroo
Feb 13, 2016·BMC Medicine·Laurent DolléBenoit Chassaing
Mar 25, 2016·International Journal of Medical Microbiology : IJMM·Alex SteimleJulia-Stefanie Frick
Jun 9, 2016·Journal of Immunology Research·Juliana de Souza ApostólicoDaniela Santoro Rosa
Jul 8, 2016·Nature·Christoph A ThaissEran Elinav
Jul 8, 2016·Nature·Kenya Honda, Dan R Littman
Jul 9, 2016·Current Opinion in Immunology·Steven G ReedMark T Orr
Jul 28, 2016·Archives of Virology·Wagner QuintilioIsaias Raw
Feb 6, 2017·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Luis G V FernandesAna L T O Nascimento
Mar 8, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cindy AudigerSylvie Lesage
Nov 4, 2017·International Journal of Molecular Sciences·Florent Cochet, Francesco Peri
Mar 23, 2018·Cellular & Molecular Immunology·Hannah M KnochelmannChrystal M Paulos
Apr 21, 2018·Current Opinion in Pharmacology·Birgit Weinberger
Jul 31, 2018·Vaccine·Beini SunKai Zhao
Nov 16, 2018·Frontiers in Physiology·Elizabeth A KennedyMegan T Baldridge
Apr 27, 2019·Annual Review of Immunology·Eric M BrownRamnik J Xavier
May 16, 2019·Nature Communications·Chandran RamakrishnaEdouard M Cantin
Dec 2, 2019·Metabolic Engineering·Yuhyun JiHak Suk Chung

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
ELISA
enzyme-linked immunosorbent assay

Software Mentioned

FlowJo LLC
PRISM
GraphPad

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.